An advanced therapeutic antibody company

Based in Cambridge, UK, we’re working to rapidly generate exceptionally high-quality, fully human antibodies for treating challenging diseases.

Learn more

We're discovering and developing antibody therapeutics

We are building a rich pipeline of assets in four main therapeutic spaces: immuno-oncology, inflammation, haematology and infectious diseases. Our most advanced assets entered IND-enabling development in 2015 with clinical studies beginning in 2017.

View our pipeline

World-leading partners

  • Bill & Melinda Gates Foundation
  • Md Anderson
  • Heptares Therapeutics
  • Novo Nordisk
View our partnerships

Come and make a difference with us

Join us in developing tomorrow's medicines: we're driven by passion for better healthcare and by compassion to make a difference. Join our experienced and successful team and help us to realise our aims.

View our vacancies